Maitri Health Technologies Corp. (“Maitri”) (CSE: MTEC) (FRA: D84), a global platform for healthcare supply security, today announced the appointment of Bridget Ross to its Advisory Board.
| VANCOUVER, BC, March 23, 2021 /PRNewswire/ - Maitri Health Technologies Corp. (“Maitri”) (CSE: MTEC) (FRA: D84), a global platform for healthcare supply security, today announced the appointment of Bridget Ross to its Advisory Board.
Ms. Ross is currently CEO of ChroniSense Medical, Ltd., an Israel-based MedTech company and maker of wearable, medical-grade disease management devices. Ms. Ross serves as a Board Director for LeMaitre Vascular Inc. (NASDAQ: LMAT) and as a mentor for early stage MedTech companies through MassMEDIC and the Canadian Consulate Technology Accelerator, in Boston, MA. For three decades, she held several executive roles at the world’s largest broadly based healthcare company, Johnson & Johnson (J&J). “Bridget brings an unmatched level of experience and success to Maitri’s extended team,” said Andrew Morton, CEO of Maitri. “Maitri is uniquely positioned to modernize healthcare systems for governments, healthcare systems and businesses to function well beyond the pandemic. Bridget’s counsel and insights on product development will be invaluable as we continue to evolve and execute our integrated PPE and technology strategy.” Ms. Ross was previously President of the Global Medical Group at Henry Schein, where she led the growth strategy for a US$2.4 billion global business. At J&J, she was appointed Vice President, Commercial Operations of its North American Medical Device Sector, after previous roles as Global President at two J&J subsidiaries, leading product innovation and sales. A graduate of the University of Alberta, Ms. Ross also previously served as a Health Sector Advisory Council Member at Duke University in North Carolina. She joins a Maitri Advisory Board that includes one of the world’s foremost specialists in infectious diseases, and an internationally recognized expert in healthcare supply systems. Along with an accomplished Advisory Board, Maitri’s Board of Directors includes a former Canadian Minister of Health and a former chief digital officer of Bayer Inc. About Maitri Health Technologies For more information: investors@maitrihealth.ca On behalf of the board of directors, MAITRI HEALTH TECHNOLOGIES CORP. Andrew Morton, Chief Executive Officer Forward-Looking Statements This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.
SOURCE Maitri Health Technologies Corp. | ||
Company Codes: CNSX:MTEC, Frankfurt:D84, OTC-PINK:MHTCF |
View original content to download multimedia:
